AlphaStocks

AZN vs PDFS

As of Sep 20, 2026, Astrazeneca (AZN) scores 5.0/10 and PDF Solutions (PDFS) 4.6/10 on AlphaStocks' five-model composite, so AZN scores higher. AZN trades 14% below its model fair value.

AZN

ASTRAZENECA PLC

5.0

Consider Buy

$166.29

PDFS

PDF SOLUTIONS INC

4.6

Weak

$44.33

AZN vs PDFS: Which is the Better Investment?

ASTRAZENECA PLC (AZN) scores 5.0/10 while PDF SOLUTIONS INC (PDFS) scores 4.6/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Consider Buy.

This comparison is algorithmically generated and is not financial advice.

MetricAZNPDFS
Scores & Fundamentals
Composite Score5.0/104.6/10
RatingConsider BuyWeak
Price$166.29$44.33
P/E Ratio25.4
ROE21.9%-0.1%
Market Cap$260B$2B
Fair Value$192.63
Dividend Yield1.9%
Sector Rank#111 of 168#139 of 205
Model Verdicts
PiotroskiStrongNeutral
BuffettStrongCaution
GrahamCautionNeutral
LynchNeutralAttractive
GreenblattNeutralCaution
View full AZNanalysis →View full PDFSanalysis →

Related comparisons

Compare any two stocks →

AZN vs PDFS: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) is in the Health Care sector; PDF SOLUTIONS INC (PDFS) is in Information Technology. AZN currently leads with a composite score of 5.0/10 (Consider Buy) compared to PDFS's 4.6/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer